Dr. Carl Sanders

Carl is a partner in the firm’s German private equity practice. He advises private equity houses and financial sponsor clients on their M&A deals, strategic investments and joint ventures.

Carl also advises sponsors on the management of their existing portfolio companies, including on management investment plans, equity financings, liquidity events and add-on transactions.

Carl regularly works on complex cross-border transactions and has gained first-hand insights having spent six months as a secondee with a financial sponsor client.

Work highlights

Carl’s recent experience includes advising:

• GTCR on the bidding process regarding the acquisition of GGW from hg
• Macquarie on

the sale of Macquarie’s Real Estate Fund Management Platform GLL Real Estate Partners

the bidding process regarding a stake in EWE AG alongside Allianz Capital Partners

• Apax Partners on 

the acquisition of Rodenstock

the acquisition of neuraxpharm

• Allianz Capital Partners on 

the acquisition of a 18% stake in ATC Europe from American Tower

its investment in Austrian fibre network company öGIG

• iCON Infrastructure on its acquisition of Alliance Medical from Life Healthcare
• Montagu Private Equity on 

its acquisition of Waystone and several add-on acquisitions

its acquisition of Universal Investment, several add-on acquisitions in Germany, Luxembourg and Ireland, as well as several minority divestments, including on the sale of a substantial minority interest to CPPIB

Carl has studied law at the University of Freiburg and at the University of Cambridge. He holds a PhD from the University of Mannheim.

He speaks German and English.